AI-generated summary
This review examines strategies for preventing and treating oral mucositis caused by chemotherapy and radiotherapy. The authors report that many preventive agents, including chlorhexidine, amifostine and glutamine, have given conflicting, inconclusive or limited results, and that most strategies rest on limited, often anecdotal, clinical data. Treatment of established mucositis is described as largely palliative.
- Who or what was studied
- Patients receiving chemotherapy or radiotherapy who are at risk of or have oral mucositis
- Limits stated in the abstract
- The abstract states that most strategies are based on limited, often anecdotal, clinical data and that several supporting studies show conflicting or inconclusive results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on accpjournals.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.